Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins

The physiological functions of the cellular prion protein, PrPC, as a cell surface pleiotropic receptor are under debate. We report that PrPC interacts with vitronectin but not with fibronectin or collagen. the binding sites mediating this PrPC-vitronectin interaction were mapped to residues 105-119 of PrPC and the residues 307-320 of vitronectin. the two proteins were co-localized in embryonic dorsal root ganglia from wild-type mice. Vitronectin addition to cultured dorsal root ganglia induced axonal growth, which could be mimicked by vitronectin peptide 307-320 and abrogated by anti-PrPC antibodies. Full-length vitronectin, but not the vitronectin peptide 307-320, induced axonal growth of dorsal root neurons from two strains of PrPC-null mice. Functional assays demonstrated that relative to wild-type cells, PrPC-null dorsal root neurons were more responsive to the Arg-Gly-Asp peptide (an integrin-binding site), and exhibited greater alpha v beta 3 activity. Our findings indicate that PrPC plays an important role in axonal growth, and this function may be rescued in PrPC-knockout animals by integrin compensatory mechanisms.Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, São Paulo, BrazilUniv São Paulo, Inst Quim, Dept Bioquim, BR-05508 São Paulo, BrazilHosp Canc, Ctr Tratamento & Pesquisa, São Paulo, BrazilUniv Fed Parana, Dept Patol Basica, BR-80060000 Curitiba, Parana, BrazilUniv Fed Parana, Dept Biol Celular, BR-80060000 Curitiba, Parana, BrazilUniversidade Federal de São Paulo, INFAR, BR-04023062 São Paulo, BrazilUniversidade Federal de São Paulo, INFAR, BR-04023062 São Paulo, BrazilWeb of Scienc

Dengue virus pathogenesis in mouse central nervous system: studies on host response to dengue virus infection

Dengue virus (DENV) causes a self-limiting fever (DF) or severe hemorrhagic fever/shock-syndrome (DHF/DSS). Recently, clinical profile of DENV infection is changing, and neurological manifestations are becoming frequent. We previously demonstrated that mutations on E and NS3 proteins may account for DENV neurovirulence for mice. To validate the involvement of the observed mutations in the appearance of neurovirulent viral phenotypes, we constructed cDNA infectious clones encompassing the observed mutations. Aiming to determine host response to infection with neurovirulent and parental strains of DENV-1, we used a Mus musculus biochip (Virginia Commonwealth University) encompassing whole mouse genome. Newborn Swiss mice were infected intracerebraly with 8.000ffuC636 of FGA/89 (parental strain), FGA/NA a5c (neurovirulent strain) and mock. Animals infected with FGA/NA a5c show clinical signs of encephalitis around 9 days post-infection (dpi) and succumb to death (13.1 dpi ± 2.2), in contrast with animals infected with FGA/89 and mock. Kinetics of infection showed higher levels of viral RNA and progeny in FGA/NA a5c infected animals at 9 dpi. Microarray analyzes were carried out at 5, 6, 7 and 8 dpi in central nervous system (CNS) of mock, FGA/89 and FGA/NA a5c infected animals. Bioinformatic analysis revealed 149 genes up-regulated in CNS infection by DENV-1, at higher levels in animals infected with FGA/NA a5c. Analysis with the software Ingenuity Pathways Systems(IPA) showed that the main pathways modulated by DENV infection in the mouse CNS are IFN signaling, antigen presentation, complement cascades and protein ubiquitination. Additionally, 15 genes were selected by in silico analyses; of special interest are four genes encoding chemokines with chemoattractant activity, that are up-regulated following infection with the neurovirulent virus compared to parental virus. Nowadays we are performing the biological characterization of the selected genes and pathways

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma

<p>Abstract</p> <p>Background</p> <p>ADAM33 protein is a member of the family of transmembrane glycoproteins composed of multidomains. ADAM family members have different activities, such as proteolysis and adhesion, making them good candidates to mediate the extracellular matrix remodelling and changes in cellular adhesion that characterise certain pathologies and cancer development. It was reported that one family member, <it>ADAM23</it>, is down-regulated by promoter hypermethylation. This seems to correlate with tumour progression and metastasis in breast cancer. In this study, we explored the involvement of ADAM33, another ADAM family member, in breast cancer.</p> <p>Methods</p> <p>First, we analysed <it>ADAM33 </it>expression in breast tumour cell lines by RT-PCR and western blotting. We also used 5-aza-2'-deoxycytidine (5azadCR) treatment and DNA bisulphite sequencing to study the promoter methylation of ADAM33 in breast tumour cell lines. We evaluated ADAM33 methylation in primary tumour samples by methylation specific PCR (MSP). Finally, <it>ADAM33 </it>promoter hypermethylation was correlated with clinicopathological data using the chi-square test and Fisher's exact test.</p> <p>Results</p> <p>The expression analysis of <it>ADAM33 </it>in breast tumour cell lines by RT-PCR revealed gene silencing in 65% of tumour cell lines. The corresponding lack of ADAM33 protein was confirmed by western blotting. We also used 5-aza-2'-deoxycytidine (5-aza-dCR) demethylation and bisulphite sequencing methodologies to confirm that gene silencing is due to <it>ADAM33 </it>promoter hypermethylation. Using MSP, we detected <it>ADAM33 </it>promoter hypermethylation in 40% of primary breast tumour samples. The correlation between methylation pattern and patient's clinicopathological data was not significantly associated with histological grade; tumour stage (TNM); tumour size; ER, PR or ERBB2 status; lymph node status; metastasis or recurrence. Methylation frequency in invasive lobular carcinoma (ILC) was 76.2% compared with 25.5% in invasive ductal carcinoma (IDC), and this difference was statistically significant (p = 0.0002).</p> <p>Conclusion</p> <p><it>ADAM33 </it>gene silencing may be related to the discohesive histological appearance of ILCs. We suggest that <it>ADAM33 </it>promoter methylation may be a useful molecular marker for differentiating ILC and IDC.</p

Interaction of the cellular prion protein with laminin and STI-1 and their possible biological implications

A conversão da proteína príon celular (PrPc) em sua isoforma anormal PrPsc está associada a uma série de doenças neurodegenerativas, genericamente designadas por doenças priônicas. Embora a literatura tenha enfatizado o estudo do PrPsc e o mecanismo de propagação das doenças de príon, pouco tem sido feito para o entendimento do papel fisiológico do PrPc. Em 1997 nosso grupo descreveu um receptor/ligante para o PrPc utilizando o princípio da hidropaticidade complementar. Neste trabalho isolamos e identificamos este ligante de PrPc como sendo a STI-1 (Stress Inducible Protein-1). In vitro, a STI-1interage com o PrPc de maneira específica, saturável e com alta afinidade (Kd=8x10-8M). Paralelamente, mostramos que o PrPc se liga ao domínio RNIAEIIKDI da laminina (Ln) (Kd=2x10-8M). O bloqueio de PrPc na superfície de neurônios hipocampais de embriões de ratos e camundongos, reduziu a neuritogênese induzida por Ln. Além disso, neurônios provenientes de animais PrP -/- são incapazes de estender neuritos sobre o peptídeo RNIAEIIKDI, sugerindo que o PrPc é o único receptor celular para este domínio da Ln. Estes dados indicam que a interação PrPc-Ln seja relevante nos fenômenos de adesão e diferenciação neuronais. A caracterização das interações PrPc-Ln e PrPc-STI-1 representa contribuições importantes para a elucidação do papel biológico do PrPc.Conversion of the cellular prion protein (PrPc) to its abnormal isoform PrPsc is associated with some neurodegenerative and fatal diseases called prion diseases. Although the literature has been emphasizing the mechanism of PrPsc conversion and illness propagation, little attention has been given to the PrPc physiological role. In 1997, our group described a PrPc receptor/ligand based on the complementary hydropathy theory. Herein, we identify the PrPc receptor/ligand as STI-1, the Stress Inducible Protein-1. In vitro studies showed that STI-1 is a specific, saturable and high affinity ligand for PrPc (Kd=8x10-8M). In parallel, we demonstrated that PrPc interacts with RNIAEIIKDI domain of laminin (Ln) (Kd=2x10-8M). The blockage of PrPc, both from embryonic rats and mice hippocampal neuros, inhibited Ln-induced neurite outgrowth. In addition, neurons from PrPc null mice are unable to extend neurites on RNIAEIIKDI, suggesting that PrPc is the unique cellular receptor for this Ln domain. These data indicate that PrPc-Ln interaction is relevant for neuronal adhesion and differentiation. The characterization of PrPc-Ln and PrPc-STl-1 interactions represents important contributions for the elucidation of the PrPc physiological role

Interaction of the cellular prion protein with laminin and STI-1 and their possible biological implications

A conversão da proteína príon celular (PrPc) em sua isoforma anormal PrPsc está associada a uma série de doenças neurodegenerativas, genericamente designadas por doenças priônicas. Embora a literatura tenha enfatizado o estudo do PrPsc e o mecanismo de propagação das doenças de príon, pouco tem sido feito para o entendimento do papel fisiológico do PrPc. Em 1997 nosso grupo descreveu um receptor/ligante para o PrPc utilizando o princípio da hidropaticidade complementar. Neste trabalho isolamos e identificamos este ligante de PrPc como sendo a STI-1 (Stress Inducible Protein-1). In vitro, a STI-1interage com o PrPc de maneira específica, saturável e com alta afinidade (Kd=8x10-8M). Paralelamente, mostramos que o PrPc se liga ao domínio RNIAEIIKDI da laminina (Ln) (Kd=2x10-8M). O bloqueio de PrPc na superfície de neurônios hipocampais de embriões de ratos e camundongos, reduziu a neuritogênese induzida por Ln. Além disso, neurônios provenientes de animais PrP -/- são incapazes de estender neuritos sobre o peptídeo RNIAEIIKDI, sugerindo que o PrPc é o único receptor celular para este domínio da Ln. Estes dados indicam que a interação PrPc-Ln seja relevante nos fenômenos de adesão e diferenciação neuronais. A caracterização das interações PrPc-Ln e PrPc-STI-1 representa contribuições importantes para a elucidação do papel biológico do PrPc.Conversion of the cellular prion protein (PrPc) to its abnormal isoform PrPsc is associated with some neurodegenerative and fatal diseases called prion diseases. Although the literature has been emphasizing the mechanism of PrPsc conversion and illness propagation, little attention has been given to the PrPc physiological role. In 1997, our group described a PrPc receptor/ligand based on the complementary hydropathy theory. Herein, we identify the PrPc receptor/ligand as STI-1, the Stress Inducible Protein-1. In vitro studies showed that STI-1 is a specific, saturable and high affinity ligand for PrPc (Kd=8x10-8M). In parallel, we demonstrated that PrPc interacts with RNIAEIIKDI domain of laminin (Ln) (Kd=2x10-8M). The blockage of PrPc, both from embryonic rats and mice hippocampal neuros, inhibited Ln-induced neurite outgrowth. In addition, neurons from PrPc null mice are unable to extend neurites on RNIAEIIKDI, suggesting that PrPc is the unique cellular receptor for this Ln domain. These data indicate that PrPc-Ln interaction is relevant for neuronal adhesion and differentiation. The characterization of PrPc-Ln and PrPc-STl-1 interactions represents important contributions for the elucidation of the PrPc physiological role

Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway

Malignant melanoma is one of the most lethal cancers. Nowadays, several anti-melanoma therapies have been employed. However, the poor prognosis and/or the increased toxicity of those treatments clearly demonstrate the requirement of searching for new drugs or novel combined chemotherapeutic protocols, contemplating both effectiveness and low toxicity. Guanosine (Guo) has been used in combination with acriflavina to potentiate the latter`s antitumor activity, through still unknown mechanisms. Here, we show that Guo induces B16F10 melanoma cell differentiation, attested by growth arrest, dendrite-like outgrowth and increased melanogenesis, and also reduced motility. A sustained ERK 1/2 phosphorylation was observed after Guo treatment and ERK inhibition led to blockage of dendritogenesis. Intracellular cyclic AMP was not involved in ERK activation, since its levels remained unchanged. Protein kinase C (PKC), in contrast to phospholipase C (PLC), inhibition completely prevented ERK activation. While the classical melanoma differentiation agent forskolin activates cAMP-PKA-Raf-MEK-ERK pathway in B16F10 cells, here we suggest that a cAMP-independent, PKC-ERK axis is involved in Guo-induced B16F10 differentiation. Altogether, our results show that Guo acts as a differentiating agent, with cytostatic rather than cytotoxic properties, leading to a decreased melanoma malignancy. Thus, we propose that Guo may be envisaged in combination with lower doses of conventional anti-melanoma drugs, in an attempt to prevent or diminish their adverse effects. (c) 2008 Elsevier Ireland Ltd. All rights reserved

Electrosprayed superhydrophobic PTFE: a non-contaminating surface

This paper reports on the exposure of superhydrophobic polytetrafluoroethylene ( PTFE) coatings to common aqueous solutions which are used in biology, biotechnology and chemical sensor applications. Advancing contact angles as high as 173 degrees for aqueous solutions were measured on the PTFE surface. Water drop sliding angles at 2 degrees show a very low contact angle hysteresis. X-ray photoelectron spectroscopy measurements confirm that aqueous solutions can move or stay on the superhydrophobic surface without contamination. Owing to the chemical inertness of the polymer, these results indicate that superhydrophobic PTFE can be used in lab-on-a-chip and multi-sensor devices as well as in biological cultures, where aqueous solutions meet solid surfaces, without contaminating the interface

MYC is activated by USP2a-mediated modulation of MicroRNAs in prostate cancer

Ubiquitin-specific protease 2a (USP2a) is overexpressed in almost half of human prostate cancers and c-Myc is amplified in one third of these tumor types. Transgenic MYC expression drives invasive adenocarcinomas in the murine prostate. We show that overexpression of USP2a downregulates a set of microRNAs that collectively increase MYC levels by MDM2 deubiquitination and subsequent p53 inactivation. By establishing MYC as a target of miR-34b/c, we demonstrate that this cluster functions as a tumor suppressor in prostate cancer cells. We identify a distinct mRNA signature that is enriched for MYC-regulated transcripts and transcription factor binding sites in USP2a overexpressing prostate cancer cells. We demonstrate that these genes are associated with an invasive phenotype in human prostate cancer and that the proliferative and invasive properties of USP2a overexpressing cells are MYC-dependent. These results highlight an unrecognized mechanism of MYC regulation in prostate cancer and suggest alternative therapeutic strategies in targeting MYC. SIGNIFICANCE: The deubiquitinating enzyme USP2a has previously been shown to be oncogenic, overexpressed in almost half of human prostate adenocarcinomas, and prolongs the half-life of targets such as fatty acid synthase, MDM2, and cyclin D1. Here, we highlight a new mechanism by which USP2a enhances MYC levels through the modulation of specific subsets of microRNAs in prostate cancer, suggesting alternative therapeutic strategies for targeting MYC